Sign in >>

News item: Corporate restructuring announced by Akela Pharma to achieve several operational objectives (News-Medical-Net)

Akela Pharma, Inc., (TSX: AKL) and its wholly owned manufacturing subsidiary, PharmaForm, today announced a comprehensive corporate restructuring designed to achieve several operational objectives.

Posted over 2 years ago

Continue reading...

Back to news index

Related sites from Google



Send feedback about this page
Email a link to this page

This topic elsewhere

Loading...
Loading...